Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?

International Journal of Neuroscience

Volumn 114, Issue 6, 2004, Pages 593-611

  Tyson, Philip J ^a   Roberts, Kate H ^b   Mortimer, Ann M ^c  

^a UNIVERSITY OF GLOUCESTERSHIRE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

5HT 2A; Atypical antipsychotics; Cognition; Dopamine; Schizophrenia; Serotonin

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A RECEPTOR;

ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; MEMORY; NEUROPHARMACOLOGY; NEUROPSYCHOLOGICAL TEST; PLANNING; PREFRONTAL CORTEX; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SEROTONINERGIC TRANSMISSION; TASK PERFORMANCE; VISUAL MEMORY;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; COGNITION; DECISION MAKING; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; RECEPTOR, SEROTONIN, 5-HT2A; SCHIZOPHRENIA; SPACE PERCEPTION; TIME FACTORS;

EID: 2542491157     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450490430552     Document Type: Article

References (44)

1. Altman, H. J., & Normile, H. J. (1988). What is the nature of the role of the serotonergic nervous system in learning and memory: Prospects for development of an effective treatment strategy for senile dementia. Neurobiological Aging, 9, 627-638.
2. Altman, H. J., Ogren, S. O., Berman, R. F., & Normile, H. J. (1989). The effects of p-chloroamphetamine, a depletor of brain serotonin, on the performance of rats in two types of positively reinforced complex spatial discrimination tasks. Behavioral and Neural Biology, 52, 131-144.
3. Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptmari, M., Sheitman, B., et al. (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 159, 1018-1028.
4. Buhot, M. C., Martin, S., & Segu, L. (2000). Role of serotonin in memory impairment. Annals of Medicine, 32, 210-221.
5. Carli, M., & Samanin, R. (1992). Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology (Berlin), 106, 228-234.
6. Carli, M., & Samanin, R. (2000). The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychopharmacology (Berlin), 149, 259-268.
7. Chaudhry, I. B., Soni, S. D., Hellewell, J. S., & Deakin, J. F. (2002). Effects of the 5HT antagonist cyproheptadine on neuropsychological function in chronic schizophrenia. Schizophrenia Research, 53, 17-24.
8. Fray, P. J., Robbins, T. W., & Sahakian, B. J. (1996). Neuropsychiatric applications of cantab. International Journal of Geriatric Psychiatry, 11, 329-336.
9. Friedman, J. L., Temporini, H., & Davis, K. L. (1999). Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biological Psychiatry, 45, 1-16.
10. Harrison, A. A., Everitt, B. J., & Robbins, T. W. (1997). Doubly dissociable effects of median and dorsal-raphe lesions on the performance of the five choice serial reaction time test of attention in rats. Behavorial Brain Research, 89, 135-149.
11. Hertel, P., Nomikos, G. G., Iurlo, M., & Svensson, T. H. (1996). Risperidone: Regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology (Berlin), 124, 74-86.
12. Hutton, S. B., Puri, B. K., Duncan, L. J., Robbins, T. W., Barnes, T. R. E., & Joyce, E. M. (1998). Executive function in first episode schizophrenia. Psychological Medicine, 28, 463-473.
13. Jakala, P., Sirvio, J., Jolkkonen, J., Riekkinen, P., Jr., Acsady, L., & Riekkinen, P. (1992). The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behavorial Brain research, 51, 29-40.
14. Keefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999). The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophrenia Bulletin, 25, 201-222.
15. Kuroki, T., Meltzer, H. Y., & Ichikawa, J. (1999). Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. Journal of Pharmacology and Experimental therapeutics, 288, 774-781.
16. Lamirault, L., & Simon, H. (2001). Enhancement of place and object recognition memory in young adult and old rats by rs 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology, 41, 844-853.
17. Leyson, J. E., Janssen, P. M. F., Heylan, L., Gommeren, W., Gompel, P. V., Lesage, A. S., Et al. (1998). Receptor interactions of new antipsychotics: relation to pharmacodynamic and clinical effects. International Journal of Psychiatry in Clinical Practice, 2, 3-17.
18. Lieberman, J. A., Mailman, R. B., Duncan, G., Sikich, L., Chakos, M., Nichols, D. E., et al. (1998). Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry, 44, 1099-1117.
19. Lindenmayer, J. P., Iskander, A., Park, M., Apergi, F. S., Czobor, P., Smith, R., et al. (1998). Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study. Journal of clinical Psychiatry, 59, 521-527.
20. Mamounas, L. A., Mullen, C. A., O'Hearn, E., & Molliver, M. E. (1991). Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. Journal of Comparative Neurology, 314, 558-586.
21. Meltzer, H. Y. (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 21, 106-115.
22. Meneses, A. (1998). Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory. Reviews in the Neurosciences, 9, 275-289.
23. Meneses, A. (1998). 5HT receptors as targets for drugs in the treatment of learning and memory dysfunctions. Current Research in Serotonin, 3, 214-235.
24. Meneses, A. (1999). 5-HT system and cognition. Neurosci. Biobehav. Rev., 23, 1111-1125.
25. Micheau, J., & Van Marrewijk, B. (1999). Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Progress in Neuropsychopharmacology and biological Psychiatry, 23, 1113-1133.
26. Milner, B. (1971). Interhemispheric differences in the localization of psychological processes in man. British Medical Bulletin, 27, 272-277.
27. Morris, R., Evenden, J., Sahakian, B., & Robbins, T. (1987). Computer aided assessment of dementia: Comparative studies of neuropsychological deficits in alzheimer type dementia and parkinson's disease. In S. Stahl, S. Iverson, & E. Goodman (eds.), Cognitive neurochemistry (pp 21-36). Oxford: Oxford university press.
28. Mortimer, A. M. (2001). The neuropsychology of chronic severe schizophrenic patients treated with clozapine versus treatment as usual. Unpublished work.
29. Nakamura, K., & Kurasawa, M. (2000). Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam. Naunyn Schmiedebengs Archives of Pharmacology, 361, 521-528.
30. Nelson, H. E. (1982). National adult reading test (nart): test manual. Windsor: NFER-Nelson.
31. Overall, J. E. (1976). The brief psychiatric rating scale in psychopharmacologic research. In G. W. Rockville (ed.), Assessment Manual for Psychopharmacology (pp. 166-169). National Institute of Mental Health, Maryland.
32. Overall, J. E., & Gorman, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799-812.
33. Pehek, E. A. (1996). Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex. Synapse, 24, 12-18.
34. Robbins, T. W., & Everitt, B. J. (1995). Arousal systems and attention. In M. Gazzaniga (Ed.), The cognitive neurosciences (pp. 703-720). Cambridge, MA: MIT press.
35. Rosse, R. B., Schwartz, B. L., Zlotolow, S., Banay-Schwartz, M., Trinidad, A. C., Peace, T. D., et al. (1992). Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia. Clinical Neuropharmacology, 15, 129-141.
36. Ruotsalainen, S., Miettinen, R., Macdonald, E., Koivisto, E., & Sirvio, J. (2000). Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion. Psychopharmacology (Berlin), 148, 111-123.
37. Schmidt, C. J., & Fadayel, G. M. (1995). The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. European Journal of Pharmacology, 273, 273-279.
38. Schmitt, J. A., Jorissen, B. L., Sobczak, S., Van Boxtel, M. P., Hogervorst, E., Deutz, N. E., et al. (2000). Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. Journal of Psychopharmacology, 14, 21-29.
39. Smith, G. S., Dewey, S. L., Brodie, J. D., Logan, J., Vitkun, S. A., Simkowitz, P., et al. (1997). Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. American Journal of Psychiatry, 154, 490-496.
40. Soperr, H. V., Elliott, R. O., Rejzer, A. A., & Marshall, B. D. (1990). Effects of fenfluramine on neuropsychological and communicative functioning in treatment-refractory schizophrenic patients. Journal of Clinical Pharmcology, 10, 168-175.
41. Steckler, T., & Sahgal, A. (1995). The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav. Brain Res., 67, 165-199.
42. Tork, I. (1990). Anatomy of the serotonergic system. Annals of the New York Academy of Sciences, 600, 9-34.
43. Tuuainen, A., Wahlbeck, K., & Gilbody, S. (2002). Newer atypical antipsychotric medication in comparison to clozapine: a systematic review of randomized trials. Schizophrenia Research, 56, 1-10.
44. Wilson, B. A., Cockburn, J., & Baddeley, A. (1985). The Rivermead Behavioural Memory Test. London: Thames.